BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37812248)

  • 1. A systematic review of qualitative research exploring patient and health professional perspectives of breakthrough cancer pain.
    Crawford GB; Lakhani A; Palmer L; Sebalj M; Rolan P
    Support Care Cancer; 2023 Oct; 31(12):619. PubMed ID: 37812248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough cancer pain (BTcP) management: a review of international and national guidelines.
    Davies AN; Elsner F; Filbet MJ; Porta-Sales J; Ripamonti C; Santini D; Webber K
    BMJ Support Palliat Care; 2018 Sep; 8(3):241-249. PubMed ID: 29875184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breakthrough cancer pain tailored treatment: which factors influence the medication choice? An observational, prospective and cross-sectional study in patients with terminal cancer.
    Magnani C; Giannarelli D; Calvieri A; Dardeli A; Eusepi G; Restuccia MR; Mastroianni C; Casale G
    Postgrad Med J; 2018 Oct; 94(1116):566-570. PubMed ID: 30317182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and Treatment of Breakthrought Pain (BTcP) in Palliative Care.
    Husic S; Imamovic S; Matic S; Sukalo A
    Med Arch; 2017 Aug; 71(4):246-250. PubMed ID: 28974843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breakthrough cancer pain: review and calls to action to improve its management.
    Camps Herrero C; Batista N; Díaz Fernández N; Escobar Álvarez Y; Gonzalo Gómez A; Isla Casado D; Salud A; Terrasa Pons J; Guillem Porta V
    Clin Transl Oncol; 2020 Aug; 22(8):1216-1226. PubMed ID: 32002739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakthrough Cancer Pain: Ten Commandments.
    Mercadante S; Cuomo A
    Value Health; 2016; 19(5):531-6. PubMed ID: 27565269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current management of breakthrough cancer pain according to physicians from pain units in Spain.
    Estévez FV; Alarcón MDL; Mayoral V; de Madariaga M; Margarit C; Duran JA; Martín-Arroyo JMT; Carregal A;
    Clin Transl Oncol; 2019 Sep; 21(9):1168-1176. PubMed ID: 30783918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fentanyl buccal tablet for breakthrough cancer pain in clinical practice: results of the non-interventional prospective study ErkentNIS.
    Masel EK; Landthaler R; Gneist M; Watzke HH
    Support Care Cancer; 2018 Feb; 26(2):491-497. PubMed ID: 28849261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breakthrough cancer pain treatment in Spain: physicians' perception of current opioids utilization and prescription.
    Villegas Estévez F; López Alarcón MD; Alonso Babarro A; Olay Gayoso L; de Castro J; Lería-Gelabert M; Melogno-Klinkas M
    Curr Med Res Opin; 2020 Aug; 36(8):1383-1391. PubMed ID: 32453602
    [No Abstract]   [Full Text] [Related]  

  • 11. Breakthrough Cancer Pain: A Systematic Review of Pharmacologic Management
.
    Brant JM; Rodgers BB; Gallagher E; Sundaramurthi T
    Clin J Oncol Nurs; 2017 Jun; 21(3 Suppl):71-80. PubMed ID: 28524907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characterization of breakthrough pain in cancer patients with proctalgia treated with 3D pelvic radiotherapy.
    Ferrero VT; Oset MM; Masferrer JP; Pardo EH; Sorolla EJ; Largo SC;
    Clin Transl Oncol; 2019 Dec; 21(12):1707-1711. PubMed ID: 30949931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study.
    Villarroel PG; Padró JG; Marquina G; Jáñez NM; González EE; Antón A; Sánchez MB; Cáceres AR; López-López R; Cornejo RE; García PB; Fabregat RM; Fernández BC; Bermudo CL; Camps C
    Future Oncol; 2022 Nov; 18(35):3913-3927. PubMed ID: 36537885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breakthrough cancer pain (BTcP): a synthesis of taxonomy, pathogenesis, therapy, and good clinical practice in adult patients in Italy.
    Zucco F; Bonezzi C; Fornasari D
    Adv Ther; 2014 Jul; 31(7):657-82. PubMed ID: 25005168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of individualized management of breakthrough cancer pain on quality of life in advanced cancer patients: CAVIDIOPAL study.
    Tuca Rodríguez A; Núñez Viejo M; Maradey P; Canal-Sotelo J; Guardia Mancilla P; Gutiérrez Rivero S; Raja Casillas I; Herrera Abián M; López Bermudo C
    Support Care Cancer; 2021 Aug; 29(8):4799-4807. PubMed ID: 33533986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of oral fentanyl formulations for breakthrough cancer pain treatment.
    Cortesi PA; D'Angiolella LS; Vellucci R; Allegri M; Casale G; Favaretti C; Kheiraoui F; Cesana G; Mantovani LG
    PLoS One; 2017; 12(6):e0179523. PubMed ID: 28654672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
    Mercadante S; Masedu F; Valenti M; Aielli F
    Oral Oncol; 2019 Aug; 95():87-90. PubMed ID: 31345399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the use of opioids for breakthrough cancer pain: A secondary analysis of the IOPS-MS study.
    Mercadante S; Adile C; Masedu F; Marchetti P; Costanzi A; Aielli F
    Eur J Pain; 2019 Apr; 23(4):719-726. PubMed ID: 30421474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knowledge and practice of the management of breakthrough cancer pain among general practitioners providing palliative care in Shanghai, China: a cross-sectional survey.
    Yu Y; Zhang P; Chen D; Jiang SF
    BMJ Open; 2023 Sep; 13(9):e073670. PubMed ID: 37770268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study.
    López López R; Camps Herrero C; Khosravi-Shahi P; Guillem Porta V; Carrato Mena A; Garcia-Foncillas J; Cruz Hernández JJ; Gascón Vilaplana P; Antón Torres A; Diaz-Rubio E; Feyjoo Saus M; Aranda Aguilar E
    Clin Transl Oncol; 2018 May; 20(5):613-618. PubMed ID: 28975575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.